AZ5104
CAS No. 1421373-98-9
AZ5104 ( AZ5104; AZ-5104; AZ 5104. Demethylated AZ9291. metabolite of AZD9291 )
Catalog No. M11764 CAS No. 1421373-98-9
AZ5104, the demethylated metabolite of AZD-9291, is a potent EGFR inhibitor.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 43 | In Stock |
|
10MG | 61 | In Stock |
|
25MG | 113 | In Stock |
|
50MG | 203 | In Stock |
|
100MG | 273 | In Stock |
|
200MG | 405 | In Stock |
|
500MG | 668 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAZ5104
-
NoteResearch use only, not for human use.
-
Brief DescriptionAZ5104, the demethylated metabolite of AZD-9291, is a potent EGFR inhibitor.
-
DescriptionAZ5104, the demethylated metabolite of AZD-9291, is a potent EGFR inhibitor with IC50 of <1 nM, 6 nM, 1 nM, and 25 nM for EGFR (L858R/T790M), EGFR (L858R), EGFR (L861Q), and EGFR (wildtype), respectively. Phase 1.
-
SynonymsAZ5104; AZ-5104; AZ 5104. Demethylated AZ9291. metabolite of AZD9291
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR (L858R); EGFR (L858R/T790M); EGFR (L861Q); EGFR (wildtype); HER2/ErbB2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1421373-98-9
-
Formula Weight485.58
-
Molecular FormulaC27H31N7O2
-
Purity>98%(HPLC)
-
SolubilityEthanol: 23 mg/mL warmed (47.36 mM); DMSO: 97 mg/mL (199.76 mM)
-
SMILESC=CC(NC1=CC(NC2=NC=CC(C3=CNC4=C3C=CC=C4)=N2)=C(OC)C=C1N(CCN(C)C)C)=O.
-
Chemical NameN-(5-((4-(1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cross DA, et al. Y Discov. 2014, 4(9), 1046-1061.
molnova catalog
related products
-
AZ5104
AZ5104, the demethylated metabolite of AZD-9291, is a potent EGFR inhibitor.
-
JBJ-04-125-02
JBJ-04-125-02 is a potent, mutant-selective, allosteric and orally active EGFR inhibitor with an IC50 of 0.26 nM for EGFRL858R/T790M. JBJ-04-125-02 can inhibit cancer cell proliferation and EGFRL858R/T790M/C797S signaling. JBJ-04-125-02 has anti-tumor activities.
-
Cephalotaxine
Cephalotaxine is an antiviral and an antitumor agent.